Filip Fogdestam
Corporate Officer/Principal chez AROCELL AB
Profil
Filip Fogdestam is currently working as a Logistics Director at AroCell AB.
Previously, he worked as a Marketing Director & General Manager at Maiia Diagnostics AB from 2012 to 2013.
He also served as a General Manager at Phadia AB and MIAB Mälainvest AB.
Mr. Fogdestam completed his undergraduate degree at the University of Uppsala and the Swedish University of Agricultural Sciences.
Postes actifs de Filip Fogdestam
| Sociétés | Poste | Début |
|---|---|---|
| AROCELL AB | Corporate Officer/Principal | - |
Anciens postes connus de Filip Fogdestam
| Sociétés | Poste | Fin |
|---|---|---|
| Maiia Diagnostics AB | Sales & Marketing | 01/09/2013 |
MIAB Mälainvest AB
 MIAB Mälainvest AB Medical SpecialtiesHealth Technology MIAB Mälainvest AB, a private company based in Uppsala, Sweden, was acquired by Phadia AB on March 02, 2006. Part of Thermo Fisher Scientific, Inc., MIAB Mälainvest AB supplies a wide range of rare and special allergens. | Corporate Officer/Principal | - |
Phadia AB
 Phadia AB Medical SpecialtiesHealth Technology Phadia AB develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. The company was founded in 2004 and is headquartered in Uppdala, Sweden. | Corporate Officer/Principal | - |
Formation de Filip Fogdestam
| University of Uppsala | Undergraduate Degree |
| Swedish University of Agricultural Sciences | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AROCELL AB | Health Technology |
| Entreprise privées | 3 |
|---|---|
Phadia AB
Phadia AB Medical SpecialtiesHealth Technology Phadia AB develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. The company was founded in 2004 and is headquartered in Uppdala, Sweden. | Health Technology |
MIAB Mälainvest AB
MIAB Mälainvest AB Medical SpecialtiesHealth Technology MIAB Mälainvest AB, a private company based in Uppsala, Sweden, was acquired by Phadia AB on March 02, 2006. Part of Thermo Fisher Scientific, Inc., MIAB Mälainvest AB supplies a wide range of rare and special allergens. | Health Technology |
| Maiia Diagnostics AB |
